Phathom Pharmaceuticals, Inc.
PHATNasdaqCIK 1783183HealthcareFiscal year ends Dec 31
All transactions: 53
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-05-03 | Takeda Pharmaceutical Co Ltd10% owner | Sale | 203 | $39.06 | $7.9k | Form 4 |
| 2021-05-03 | Takeda Pharmaceutical Co Ltd10% owner | Sale | 11,272 | $38.45 | $433.4k | Form 4 |
| 2021-05-03 | Takeda Pharmaceutical Co Ltd10% owner | Sale | 3,157 | $37.60 | $118.7k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 2, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.